OneCell Diagnostics’ Mohan Uttarwar Discusses Liquid Biopsy Breakthroughs And The Future Of Precision Oncology

Firm Co-Founder Outlines How Science Meets Scale In Second Part Of The Interview

 
• By Shubham Singh

OneCell’s co-founder Uttarwar discusses clinical validation milestones, CLIA certification, and the startup’s strategic roadmap – from hospital partnerships in India to biopharma collaborations in the US.

As the company gears up for its presence at AACR 2025, this part of the discussion provides a revealing look at the intersection of science, startup execution, and the evolving business of cancer diagnostics.

More from Interviews

More from Medtech Insight